John M. Kane, MD

Original Research

Partial Compliance and Patient Consequences in Schizophrenia: Our Patients Can Do Better.

November 15, 2003

Article

Clinical Guidelines: Dosing and Switching Strategies for Long-Acting Risperidone

November 1, 2003

Article

Strategies for Improving Compliance in Treatment of Schizophrenia by Using a Long-Acting Formulation of an Antipsychotic: Clinical Studies

November 1, 2003

Supplement Article

Pharmacologic Treatment for Psychopathology

October 1, 2003

Rate the appropriateness as initial pharmacologic treatment for a patient with predominantly positive psychopathology.

Supplement Article

Guidelines

October 1, 2003

Supplement Article

Introduction: Methods, Commentary, and Summary

October 1, 2003

Original Research

An Integrated Analysis of Acute Treatment-Emergent Extrapyramidal Syndrome in Patients With Schizophrenia During Olanzapine Clinical Trials: Comparisons With Placebo, Haloperidol, Risperidone, or Clozapine

August 15, 2003

Original Research

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

September 23, 2002

Original Research

Clinical Predictors of Response to Clozapine Treatment in Ambulatory Patients With Schizophrenia

May 12, 2002

Article

Dose Selection and Comparator Drugs in Schizophrenia Research

August 1, 2001

Article

Management Strategies for the Treatment of Schizophrenia

December 1, 1999

Article

Tardive Dyskinesia in Affective Disorders

May 1, 1999